Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, open, parallel group, active comparator, single center trial.
Objectives of the study are hereby given below:
- To study the health related quality of life (HRQOL) in patients with chronic liver
disease.
- To assess the prevalence of minimal hepatic encephalopathy (MHE) in patients with
chronic liver disease and assessment of HRQOL in patients with MHE.
- To compare the effect of probiotics and lactulose in the treatment of MHE
- To assess the effect of probiotics and lactulose on the HRQOL in patients with MHE.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
CD Pharma India Pvt. Ltd.
Collaborators:
All India Institute of Medical Sciences, New Delhi Indian Council of Medical Research